Meiosis-specific recombinase Dmc1 is a potent inhibitor of the Srs2 antirecombinase.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30301803.
- Also identified by DOI 10.1073/pnas.1810457115 and PMC identifier 6205449.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cross-over recombination products are a hallmark of meiosis because they are necessary for accurate chromosome segregation and they also allow for increased genetic diversity during sexual reproduction. However, cross-overs can also cause gross chromosomal rearrangements and are therefore normally down-regulated during mitotic growth. The mechanisms that enhance cross-over product formation upon entry into meiosis remain poorly understood. In <i>Saccharomyces cerevisiae</i>, the Superfamily 1 (Sf1) helicase Srs2, which is an ATP hydrolysis-dependent motor protein that actively dismantles recombination intermediates, promotes synthesis-dependent strand annealing, the result of which is a reduction in cross-over recombination products. Here, we show that the meiosis-specific recombinase Dmc1 is a potent inhibitor of Srs2. Biochemical and single-molecule assays demonstrate that Dmc1 acts by inhibiting Srs2 ATP hydrolysis activity, which prevents the motor protein from undergoing ATP hydrolysis-dependent translocation on Dmc1-bound recombination intermediates. We propose a model in which Dmc1 helps contribute to cross-over formation during meiosis by antagonizing the antirecombinase activity of Srs2.
Medical subject headings
- Cell Cycle Proteins
- DNA Helicases
- DNA-Binding Proteins
- Meiosis
- Recombinases
- Saccharomyces cerevisiae
- Saccharomyces cerevisiae Proteins